Recent Progress in Tumor Virology Research

Clinical trials have indicated that oncoviruses might be developed as safe and effective anticancer agents. No​vel strategies can be used to facilitate viral evasion of the immune system, the prevention of viral uptake by the liver, and an increased specificity for tumour cells, either at the cell surface or through intracellular restriction.

  • The search for novel tumor viruses
  • Understanding human carcinogenesis by using tumor viruses as experimental tools
  • Defense against the use of viruses in bioterrorism

Related Conference of Recent Progress in Tumor Virology Research

January 21-22, 2021

7th Rare Diseases and Orphan Drugs

Vienna, Austria
February 15-16, 2021

8th International Congress on Infectious Diseases

London, UK
May 10-11, 2021

4th Global Experts Meeting on Infectious Diseases

Singapore City, Singapore
August 16-17, 2021

13th Global Infections Conference

Tokyo, Japan
September 06-07, 2021

11th World Congress on Rare Diseases and Orphan Drugs

Berlin, Germany

Recent Progress in Tumor Virology Research Conference Speakers

Recommended Sessions

Related Journals

Are you interested in